Digital ophthalmology technology company Eyenovia (Eyen) has become the first publicly released US company to create a high lipid (hype) reserve. The company has revealed its plans to invest $50 million to fund its hype financial strategy.
Additionally, Ainovia will undergo a Hyperion Defi rebranding with stock tickers moving from Aien to HYPD, expected around June 20th. Despite this shift, Eyenovia is committed to its core business.
High lipids (hype) gain traction as a new institution’s favorite
In its latest press release, Eyenovia announced it is raising funds through pipe finance transactions under a securities purchase agreement with accredited investors at the institution. Funding includes issuing non-voting convertible preferred shares that can be converted to approximately 15.4 million common shares at $3.25 per share.
The company will also issue warrants to purchase up to 30.8 million shares at the same strike price. If all warrants are exercised, potential revenue could reach $150 million. However, this outcome is uncertain.
“The recruitment closure is expected to occur around June 20, 2025. This is expected to result in satisfaction with the customary closure conditions and the company will change the names and tickers of “Hyperion Defi” and “Hypd” respectively,” the press release read.
The funding will help the company become one of the leading global validators of high lipids by driving the acquisition of over 1,000,000 hype tokens. They will also launch a hype staking program.
This initiative supports our long-term goal of delivering value to shareholders by leveraging the global growth of blockchain technology and digital innovation. Hype Advertising To lead the financial strategy, the medical technology company has appointed Hyun Soo Jung as Chief Investment Officer and Board Member.
Eyenovia currently joins several other companies diversifying beyond Bitcoin (BTC) and Ethereum (ETH) and employs a wider range of altcoins, including XRP (XRP), Solana (SOL), Artificial Total Alliance (FET), and Bitenser (TAO).
“We are pleased to participate in the increase in companies that have adopted similar strategies due to the diversification, liquidity and the potential for long-term capital rises that cryptocurrencies represent. Following a thorough review of all available alternatives, we concluded that this transaction is the greatest profit of our shareholders.
The strategic pivot proved to be beneficial to Ainovia’s inventory. With the market closure, prices rose 134.6%, reflecting strong investors’ confidence. Nevertheless, Eyen’s price fell 7.7% in trading outside of business hours.
Meanwhile, the hype didn’t appear to be affected by the news. Beincrypto reported that Defi Token was a record hit yesterday.
However, prices have fallen. At the time of writing, the hype was trading for $41.
Disclaimer
In compliance with Trust Project guidelines, Beincrypto is committed to reporting without bias and transparent. This news article is intended to provide accurate and timely information. However, we recommend that readers independently examine facts and consult with experts before making decisions based on this content. Please note that our terms and conditions, privacy policy and disclaimer have been updated.
